Boundless Bio, Inc. (Nasdaq:BOLD)
Health Care/Life Sciences • Biotechnology
CIK 1782303
Company
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Address
9880 Campus Point Drive
Suite 120
San Diego, California 92121
9880 Campus Point Drive
Suite 120
San Diego, California 92121
Employees
72
72
Stock Info
Key Executives
Board Of Directors
Chairman Jonathan E. Lim |
President, Chief Executive Officer & Director Zachary D. Hornby |
Independent Director Kristina Marie Burow |
Independent Director James G. Christensen |
Independent Director Christine Brennan |
SEC filings
Date | Form | Event |
---|---|---|
12 Dec, 2024 | 8-K | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
29 Oct, 2024 | SC 13D | |
15 Oct, 2024 | 8-K | |
15 Oct, 2024 | 3 | |
20 Aug, 2024 | 4 | |
20 Aug, 2024 | 4 | |
20 Aug, 2024 | 8-K | |
20 Aug, 2024 | 4 | |
20 Aug, 2024 | 4 | |
20 Aug, 2024 | 4 | |
20 Aug, 2024 | 4 | |
12 Aug, 2024 | 8-K | |
12 Aug, 2024 | 10-Q | |
20 Jun, 2024 | 4 | |
13 May, 2024 | 10-Q | |
13 May, 2024 | 8-K | |
12 Apr, 2024 | SC 13G | |
12 Apr, 2024 | SC 13G | |
10 Apr, 2024 | SC 13G | |
9 Apr, 2024 | SC 13G | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
2 Apr, 2024 | 8-K | |
2 Apr, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
29 Mar, 2024 | 4 | |
28 Mar, 2024 | 424B4 | IPO completed |
28 Mar, 2024 | S-8 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | EFFECT | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | CERT | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
27 Mar, 2024 | 3 | |
25 Mar, 2024 | CORRESP | |
25 Mar, 2024 | CORRESP | |
22 Mar, 2024 | 8-A12B | |
21 Mar, 2024 | S-1/A | |
15 Mar, 2024 | CORRESP | |
13 Mar, 2024 | UPLOAD | |
8 Mar, 2024 | CORRESP | |
6 Mar, 2024 | CORRESP | |
6 Mar, 2024 | S-1 | |
29 Jan, 2024 | UPLOAD | |
23 Jan, 2024 | DRS/A | |
11 Oct, 2023 | DRS/A | |
11 Oct, 2023 | DRSLTR | |
29 Sep, 2023 | UPLOAD | |
1 Sep, 2023 | DRS | |
15 Aug, 2023 | D | |
4 May, 2021 | D |
Last update:2025-03-06 12:02:05.474572
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.